Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 5, 2010, Pages

  Coon, Keith D ^a   Inge, Landon J ^a   Swetel, Kristen ^a   Felton, Valerie ^a   Stafford, Phillip ^b   Bremner, Ross M ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; THORACOTOMY;

EID: 77950873639     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.022     Document Type: Article

References (25)

1. Pape H.C., Tsukamoto T., Kobbe P., Tarkin I., Katsoulis S., and Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury 38 (2007) 1358-1364
2. Chyczewska E., and Mroz R.M. Cytokines in lung cancer. Rocz Akad Med Bialymst 42 suppl 1 (1997) 8-22
3. Craig S.R., Leaver H.A., Yap P.L., Pugh G.C., and Walker W.S. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg 20 (2001) 455-463
4. Franke A., Lante W., Fackeldey V., Becker H.P., Kurig E., Zoller L.G., et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?. Eur J Cardiothorac Surg 28 (2005) 569-575
5. Shiromizu A., Suematsu T., Yamaguchi K., Shiraishi N., Adachi Y., and Kitano S. Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery 128 (2000) 799-805
6. Zimmermann A.K., Simon P., Seeburger J., Hoffmann J., Ziemer G., Aebert H., et al. Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real-time PCR. J Cell Mol Med 7 (2003) 146-156
7. Seeburger J., Hoffmann J., Wendel H.P., Ziemer G., and Aebert H. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Circulation 112 suppl (2005) I224-I228
8. Tsuchiya Y., Sawada S., Yoshioka I., Ohashi Y., Matsuo M., Harimaya Y., et al. Increased surgical stress promotes tumor metastasis. Surgery 133 (2003) 547-555
9. Carvalho B., Clark D.J., and Angst M.S. Local and systemic release of cytokines, nerve growth factor, prostaglandin E2, and substance P in incisional wounds and serum following cesarean delivery. J Pain 9 (2008) 650-657
10. Kurosawa S., and Kato M. Anesthetics, immune cells, and immune responses. J Anesth 22 (2008) 263-277
11. Hirai T., Yoshimoto A., Iwata T., Yamashita Y., Kuwahara M., and Toge T. Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygen in its mechanism. Surg Today 27 (1997) 1040-1045
12. Diperna C.A., Bart R.D., Sievers E.M., Ma Y., Starnes V.A., and Bremner R.M. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma. J Thorac Cardiovasc Surg 126 (2003) 1129-1133
13. Velentgas P., West W., Cannuscio C.C., Watson D.J., and Walker A.M. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 15 (2006) 641-652
14. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15 (2008) 2042-2052
15. Benjamini B., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57 (1995) 289-300
16. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
17. Youn B.S., Yu K.Y., Oh J., Lee J., Lee T.H., and Broxmeyer H.E. Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 7 (2002) 271-276
18. Feng L.Y., Ou Z.L., Wu F.Y., Shen Z.Z., and Shao Z.M. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 15 (2009) 2962-2970
19. Robertson M.J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71 (2002) 173-183
20. Wang J.M., Deng X., Gong W., and Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220 (1998) 1-17
21. Backhus L.M., Petasis N.A., Uddin J., Schonthal A.H., Bart R.D., Lin Y., et al. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer. J Thorac Cardiovasc Surg 130 (2005) 1406-1412
22. Welch J.S., Escoubet-Lozach L., Sykes D.B., Liddiard K., Greaves D.R., and Glass C.K. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 277 (2002) 42821-42829
23. Greenlee K.J., Corry D.B., Engler D.A., Matsunami R.K., Tessier P., Cook R.G., et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 177 (2006) 7312-7321
24. Swank D.W., and Moore S.B. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc 64 (1989) 1118-1132
25. Faist E., Storck M., Hultner L., Redl H., Ertel W., Walz A., et al. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery 112 (1992) 562-572